SCHEMBL9936

SCHEMBL9936

CCOC(=O)C1(c2ccc(-c3ccccc3)c(-c3onc(C)c3Nc3cccc(OC4CCC4)n3)c2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT2 Q96PD7 1/20 0.36
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
OPRM1 P35372 6/20 0.34
LPAR1 Q92633 4/20 0.34
ABCC3 O15438 1/20 0.34
ABCC4 O15439 1/20 0.34
ABCB11 O95342 1/20 0.34
CYP2C8 P10632 1/20 0.34
CYP2C9 P11712 1/20 0.34
ABCB4 P21439 1/20 0.34
ABCC2 Q92887 1/20 0.34
SLCO1B3 Q9NPD5 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
LPAR3 Q9UBY5 3/20 0.34
OPRD1 P41143 3/20 0.32
OPRK1 P41145 3/20 0.32
SLC22A1 O15245 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937 0.93 LPAR1 (0.37) LMNATSHRNPSR1TDP1OPRM1
SCHEMBL10249 0.92 LPAR1 (0.41) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL10389 0.90 LPAR1 (0.41) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL9881 0.88 LMNA (0.34) DGAT2LMNATSHRNPSR1TDP1
SCHEMBL9878 0.88 OPRM1 (0.38) LMNATSHRNPSR1TDP1OPRM1
SCHEMBL4818 0.87 LPAR1 (0.42) DGAT2LMNATSHRNPSR1TDP1
SCHEMBL9783 0.86 OPRM1 (0.38) LMNATSHRNPSR1TDP1OPRM1
SCHEMBL10135 0.86 LMNA (0.39) LMNATSHRNPSR1TDP1OPRM1
SCHEMBL10250 0.86 LPAR1 (0.46) LPAR1ABCC3ABCC4ABCB11CYP2C8
SCHEMBL10052 0.85 KCNA3 (0.35) LMNATSHRNPSR1TDP1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483251-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed